XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference in Washington D.C. Barton Haynes from the Duke Human Vaccine Institute (DHVI) has been working in the HIV vaccine field since 1985. Here he talks about the scientific difficulties of finding an HIV vaccine.

Dr Anthony Fauci from the National Institutes of Health (NIH) gives his thoughts on the future of the AIDS epidemic. He also talks about the targets of the current and future HIV/AIDS research and about international partnerships in the AIDS response.

XIX International AIDS Conference in Washington D.C. Interview with the French Virologist, Françoise Barré-Sinoussi, winner of the Nobel Prize in Physiology or Medicine 2008 for discovering HIV as the cause of AIDS. Here she talks about the possibility of ending AIDS.

XIX International AIDS Conference in Washington D.C. Interview with the French Virologist, Françoise Barré-Sinoussi, winner of the Nobel Prize in Physiology or Medicine 2008 for discovering HIV as the cause of AIDS. Here she talks about the possibility of ending AIDS.

XIX International AIDS Conference. Interview with Shomyseh Sanjabi who is a basic Immunlogist at Gladstone Institutes. She tells about their animal model studies of HIV transmission and ageing with HIV. She is part of the CNIHR program.

XIX International AIDS Conference in Washington D.C. Interview with Takayuki Ota from The Scripps Research Institute in La Hoia, San Diego. He is part of the Creative and Novel Ideas in HIV Research Grants Program (CNIHR), a IAS and NIH collaboration.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Gretchen Neigh is a neurologist at Emory University in Atlanta working with basic research on depression. She tells about her current work on depression in HIV positive rats and her future hopes for research in humans.

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.